BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

LifeScience

Utah’s Co-Diagnostics Expands Global Footprint with Saudi Joint Venture

Governor Spencer Cox joins Kelvyn Cullimore of BioUtah in recognizing Co-Diagnostics, Inc. (Nasdaq: CODX), a Utah diagnostics company with a...

November 13, 2025 | News

Agilent and University of Melbourne Establish Agilent Innovation Hub to Advance Environmental Health Research

Partnership underscores Agilent’s expansion across Asia, including recent establishment of Centres of Excellence within flagship university campuse...

November 13, 2025 | News

MGI Tech, SAMRC and DSTI Launch Africa’s First DNBSEQ-T7 Sequencer and 110K Human Genome Program in South Africa

MGI Tech Co., Ltd., a company dedicated to developing core tools and technologies that drive innovation in life sciences, announced two historic milestones...

November 12, 2025 | News

Waters Launches Empower-Integrated Charged Aerosol Detector to Enhance LC-CAD Accuracy and Reliability

Drives efficiency and reliability in Quality Control and Development environments, integrating seamlessly with world-class Empower™ Chromatography ...

November 12, 2025 | News

Samsung Epis Holdings Launches Epis NexLab to Advance Next-Generation Biotechnology Platforms

Samsung Epis Holdings Co., Ltd. announced the establishment of Epis NexLab Co., Ltd., a new subsidiary that will focus on the development o...

November 12, 2025 | News

Primrose Bio Launches Prima RNApols™ ExTend Cap AU to Enhance Self-Amplifying mRNA Vaccine Manufacturing

Primrose Bio, Inc. ("Primrose"), a company with proprietary therapeutic manufacturing technologies, announced the launch of Prima RNApols™ ...

November 11, 2025 | News

Leucid Bio Reports Proof-of-Concept for LEU011 CAR-T Therapy in Solid Tumours from Ongoing AERIAL Trial

Proof-of-concept established for LEU011 in the treatment of relapsed/refractory solid tumours LEU011 has been well tolerated, with disease control obser...

November 11, 2025 | News

ERS Genomics Grants CRISPR/Cas9 Patent Access to Dyadic to Advance Animal-Free Protein and Enzyme Production

ERS Genomics Limited ('ERS'), the CRISPR licensing company, and Dyadic Applied BioSolutions ('Dyadic'), a global biotechnology company producing precision-...

November 11, 2025 | News

Akeso Initiates First-in-Human Trial of Personalised mRNA Vaccine AK154 for Pancreatic Cancer

Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vacc...

November 11, 2025 | News

High-Throughput Vaccine Production: The Future of Scalable, Rapid Immunisation

Vaccines remain the cornerstone of infectious disease control, but traditional development pathways are slow and resource‐intensive. Modern chall...

November 10, 2025 | Analysis

Eli Lilly Partners with SanegeneBio to Advance RNAi Therapies for Metabolic Diseases

-Companies will collaborate on RNAi research for metabolic disease targets SanegeneBio, a clinical-stage biotechnology company developing innov...

November 10, 2025 | News

Eyexora Establishes Co-Headquarters in Singapore to Drive Global Ophthalmic Innovation

-Eyexora, a biotech company pioneering innovative therapies for ophthalmic diseases through a hub-and-spoke model, announced the establishment of its co-he...

November 07, 2025 | News

Tenpoint Therapeutics and Zhaoke Ophthalmology Advance BRIMOCHOL™ PF Toward Global Market with NDA Filing in South Korea

Submission of New Drug Application (NDA) in South Korea by Zhaoke Ophthalmology Ltd.’s local partner, Kwangdong Pharmaceutical Co., Ltd., marks the...

November 07, 2025 | News

Samsung Bioepis Reaches Settlement with J&J on Stelara Biosimilar PYZCHIVA in Europe

Samsung Bioepis Co., Ltd. has signed a settlement and license agreement with Johnson & Johnson concerning the commercialization of PYZCHIVA®, a bio...

November 07, 2025 | News

Stay Connected